SCI时时刷

search
+
Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicenter, retrospective cohort study
Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicenter, retrospective cohort study
Abstract -
Secukinumab dosing every two weeks demonstrated superior efficacy compared with dosing every four weeks in patients with psoriasis weighing 90 kg or more: Results of a randomised controlled trial
Secukinumab dosing every two weeks demonstrated superior efficacy compared with dosing every four weeks in patients with psoriasis weighing 90 kg or more: Results of a randomised controlled trial
Abstract Background Obesity is a common comorbidity of psoriasis and can attenuate response to biologic treatment. Objecti...
Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase 2 studies
Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase 2 studies
Summary Background Janus kinase (JAK)-mediated cytokine signaling contributes to local and systemic inflammation in hidrad...
Prevalence and incidence of generalised pustular psoriasis in Sweden – a population‐based register study
Prevalence and incidence of generalised pustular psoriasis in Sweden – a population‐based register study
Summary Background Generalised pustular psoriasis (GPP) is a severe form of pustular psoriasis with generalised eruption o...
Response to ‘Validation of Generalized Drug‐Related Rash Diagnoses Using ICD‐9 and ICD‐10 Codes’
Response to ‘Validation of Generalized Drug‐Related Rash Diagnoses Using ICD‐9 and ICD‐10 Codes’
Abstract -
Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐blind multicentre study
Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐blind multicentre study
Summary Background Bimekizumab is a monoclonal antibody that selectively inhibits both interleukin (IL)-17A and IL-17F, wh...
Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid
Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid
Dear Editor, Pemphigoid is a heterogeneous group of rare and chronic autoimmune subepidermal bullous diseases, characteriz...
Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration
Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration
Summary Background For patients with early American Joint Committee on Cancer (AJCC)-stage melanoma the combined loss of t...
A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence
A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence
Summary Background Basal cell carcinoma (BCC) is the most frequently diagnosed malignancy worldwide and an ever increasing...
Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis
Postinflammatory hyperpigmentation and erythema: new insights into the pathogenesis
Early View Commentary J.S.S. Concha, J.S.S. Concha Corporal Michael J....
Targeting the neonatal Fc receptor in pemphigus: safety first
Targeting the neonatal Fc receptor in pemphigus: safety first
Early View Commentary G. Micevic, Corresponding Author G. Micevic ...
Response to ‘Validation of Generalized Drug‐Related Rash Diagnoses Using ICD‐9 and ICD‐10 Codes’: reply from authors
Response to ‘Validation of Generalized Drug‐Related Rash Diagnoses Using ICD‐9 and ICD‐10 Codes’: reply from authors
Accepted Articles LETTER TO THE EDITOR Michael Goldenberg, Corresponding Author ...
Pustular frontal fibrosing alopecia: a new variant within the folliculitis decalvans and lichen planopilaris phenotypic spectrum?
Pustular frontal fibrosing alopecia: a new variant within the folliculitis decalvans and lichen planopilaris phenotypic spectrum?
Corresponding Author Alejandro Lobato-Berezo Department of...
Incidence and trends of basal cell carcinoma in Sweden: A population‐based registry study
Incidence and trends of basal cell carcinoma in Sweden: A population‐based registry study
Summary Background Basal cell carcinoma (BCC) is the most common skin cancer. Incidence is largely unknown because of inco...
The biological basis of disease recurrence in psoriasis: a historical perspective and current models
The biological basis of disease recurrence in psoriasis: a historical perspective and current models
Summary A key challenge in psoriasis therapy is the tendency for lesion recurrence in previously affected anatomical locat...
Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo‐controlled, randomized, phase III clinical trial (ECZTRA 7)
Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo‐controlled, randomized, phase III clinical trial (ECZTRA 7)
Summary Background Patients with severe atopic dermatitis (AD) not controlled with topical therapy have limited treatment ...
Perineal cutaneous basal cell carcinomas in patients with familial seronegative coeliac disease: report of three cases
Perineal cutaneous basal cell carcinomas in patients with familial seronegative coeliac disease: report of three cases
Early View Research letter W.C. Lambert, Corresponding Author W.C. Lam...
Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate‐to‐severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long‐term studies
Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate‐to‐severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long‐term studies
Summary Background Interleukin (IL)-31 affects the inflammatory response, is involved in epidermal barrier disruption in a...
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway
Summary Background Epithelioid haemangioma (EH) arising from the skin is a benign vascular tumour with marked inflammatory...
Early tumour response assessment may avoid serious immune‐related adverse events in nivolumab and ipilimumab combination therapy for stage IV melanoma
Early tumour response assessment may avoid serious immune‐related adverse events in nivolumab and ipilimumab combination therapy for stage IV melanoma
Early View Research letter T. Maeda, Corresponding Author T. Maeda ...
How can we assess severity and treatments in frontal fibrosing alopecia?
How can we assess severity and treatments in frontal fibrosing alopecia?
Linked Article: Olsen et al. Br J Dermatol 2021; 185:1221–1231. Frontal fibrosing alopecia (FFA) is one o...
T 细胞和白介素‐17A 在白塞病中的作用
T 细胞和白介素‐17A 在白塞病中的作用
Linked Article: Vural et al. Br J Dermatol 2021; 185:1209–1220. 白塞病 (BD) 是&#x...
探讨小汗腺汗孔癌的新治疗策略
探讨小汗腺汗孔癌的新治疗策略
Linked Article: Westphal et al. Br J Dermatol 2021; 185:1186–1199. 小汗腺汗ֵ...
The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database
The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database
Abstract Background The NHS Epidermolysis Bullosa (EB) service set up in 2002 offers comprehensive, free care to all patie...
Latent Class Analysis Identification of Prurigo Nodularis Comorbidity Phenotypes
Latent Class Analysis Identification of Prurigo Nodularis Comorbidity Phenotypes
Abstract -
New Insights in Hidradenitis Suppurativa from a Population‐based Dutch Cohort: Prevalence, Smoking Behaviour, Socioeconomic Status and Comorbidities
New Insights in Hidradenitis Suppurativa from a Population‐based Dutch Cohort: Prevalence, Smoking Behaviour, Socioeconomic Status and Comorbidities
Summary Introduction Hidradenitis suppurativa (HS) is a chronic, auto-inflammatory skin condition and is associated with s...
A nationwide study evaluating the association of autoimmune bullous diseases and acquired haemophilia: description of clinical and prognostic features
A nationwide study evaluating the association of autoimmune bullous diseases and acquired haemophilia: description of clinical and prognostic features
Abstract -
Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema‐prone, skin
Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema‐prone, skin
Abstract Background The skin of atopic dermatitis (AD) patients is characterised by abnormal stratum corneum (SC) lipid le...
Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts
Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts
Summary Background Previous studies suggest polygenic risk scores (PRS) may improve melanoma risk stratification. However,...
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid
Summary Background European guidelines propose a 0·5 mg kg−1 per day dose of oral prednisone as init...
阅读更多
format_indent_increase